Temporal and spatial control of growth factor gradients is critical for tissue patterning and differentiation. Reinitiation of this developmental program is also required for regeneration of tissues during wound healing and tissue regeneration. Devising methods for reconstituting growth factor gradients remains a central challenge in regenerative medicine. In the current study we develop a novel gene therapy approach for temporal and spatial control of two important growth factors in bone regeneration, vascular endothelial growth factor, and bone morphogenetic protein 2, which involves application of high intensity focused ultrasound to cells engineered with a heat-activated- and ligand-inducible gene switch. Induction of transgene expression was tightly localized within cell-scaffold constructs to subvolumes of ∼30 mm3, and the amplitude and projected area of transgene expression was tuned by the intensity and duration of ultrasound exposure. Conditions for ultrasound-activated transgene expression resulted in minimal cytotoxicity and scaffold damage. Localized regions of growth factor expression also established gradients in signaling activity, suggesting that patterns of growth factor expression generated by this method will have utility in basic and applied studies on tissue development and regeneration.
Get full access to this article
View all access options for this article.
References
1.
MaesC., and CermelietG.Vascular and nonvascular roles of VEGF in bone development. In: RuhrbergC., ed. VEGF in Development. Springer, Austin, pp. 79–90, 2008.
2.
ChoiK-S., LeeC., MaatoukD.M., and HarfeB.D.Bmp2, Bmp4 and Bmp7 are co-required in the mouse AER for normal digit patterning but not limb outgrowth. PLoS One, 7, e37826, 2012.
3.
BénazetJ-D., BischofbergerM., TieckeE., GonçalvesA., MartinJ.F., ZunigaA., et al.A self-regulatory system of interlinked signaling feedback loops controls mouse limb patterning. Science, 323, 1050, 2009.
GerstenfeldL.C., CullinaneD.M., BarnesG.L., GravesD.T., and EinhornT.A.Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem, 88, 873, 2003.
6.
YuY.Y., LieuS., LuC., and ColnotC.Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. Bone, 47, 65, 2010.
7.
RutherfordR.B., MoalliM., FranceschiR.T., WangD., GuK., and KrebsbachP.H.Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng, 8, 441, 2002.
8.
BaltzerA., LattermannC., WhalenJ., WooleyP., WeissK., GrimmM., et al.Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther, 7, 734, 2000.
9.
LiebermanJ.R., DaluiskiA., StevensonS., WuL., McAllisterP., LeeY.P., et al.The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am, 81, 905, 1999.
10.
MoutsatsosI.K., TurgemanG., ZhouS., KurkalliB.G., PelledG., TzurL., et al.Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther, 3, 449, 2001.
11.
KohJ-T., GeC., ZhaoM., WangZ., KrebsbachP.H., ZhaoZ., et al.Use of a stringent dimerizer-regulated gene expression system for controlled BMP2 delivery. Mol Ther, 14, 684, 2006.
12.
AxelradT.W., SteenB., LowenbergD.W., CreevyW.R., and EinhornT.A.Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients. J Bone Joint Surg Br, 90, 1617, 2008.
13.
DmitrievA.E., CastnerS., LehmanR.A., LingG.S.F., and SymesA.J.Alterations in recovery from spinal cord injury in rats treated with recombinant human bone morphogenetic protein-2 for posterolateral arthrodesis. J Bone Joint Surg, 93, 1488, 2011.
14.
CarrageeE.J., HurwitzE.L., and WeinerB.K.A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J, 11, 471, 2011.
15.
Martín-SaavedraF.M., WilsonC.G., VoellmyR., VilaboaN., and FranceschiR.T.Spatiotemporal control of vascular endothelial growth factor expression using a heat-shock-activated, rapamycin-dependent gene switch. Hum Gene Ther Methods, 24, 160, 2013.
16.
RanjanA., JacobsG.C., WoodsD.L., NegussieA.H., PartanenA., YarmolenkoP.S., et al.Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. J Control Release, 158, 487, 2012.
17.
PartanenA., TillanderM., YarmolenkoP.S., WoodB.J., DreherM.R., and KohlerM.O.Reduction of peak acoustic pressure and shaping of heated region by use of multifoci sonications in MR-guided high-intensity focused ultrasound mediated mild hyperthermia. Med Phys, 40, 013301, 2013.
18.
Logeart-AvramoglouD., BourguignonM., OudinaK., Dijke TenP., and PetiteH.An assay for the determination of biologically active bone morphogenetic proteins using cells transfected with an inhibitor of differentiation promoter-luciferase construct. Anal Biochem, 349, 78, 2006.
19.
KruseD.E., MackanosM.A., O'Connell-RodwellC.E., ContagC.H., and FerraraK.W.Short-duration-focused ultrasound stimulation of Hsp70 expression in vivo. Phys Med Biol, 53, 3641, 2008.
20.
KempenD.H.R., LuL., HeijinkA., HefferanT.E., CreemersL.B., MaranA., et al.Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials, 30, 2816, 2009.
21.
De la RivaB., SánchezE., HernándezA., ReyesR., TamimiF., López-CabarcosE., et al.Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration. J Control Release, 143, 45, 2010.
22.
KolambkarY.M., BoerckelJ.D., DupontK.M., BajinM., HuebschN., MooneyD.J., et al.Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects. Bone, 49, 485, 2011.
23.
SmithR.C., MachlufM., BromleyP., AtalaA., and WalshK.Spatial and temporal control of transgene expression through ultrasound-mediated induction of the heat shock protein 70B promoter in vivo. Hum Gene Ther, 13, 697, 2002.
24.
DeckersR., QuessonB., ArsautJ., EimerS., CouillaudF., and MoonenC.T.W.Image-guided, noninvasive, spatiotemporal control of gene expression. Proc Natl Acad Sci U S A, 106, 1175, 2009.
25.
WalkerW.F.Internal deformation of a uniform elastic solid by acoustic radiation force. J Acoust Soc Am, 105, 2508, 1999.
26.
SarvazyanA.P., RudenkoO.V., and NyborgW.L.Biomedical applications of radiation force of ultrasound: historical roots and physical basis. Ultrasound Med Biol, 36, 1379, 2010.
27.
GossS.A., JohnstonR.L., and DunnF.Compilation of empirical ultrasonic properties of mammalian tissues. II J Acoust Soc Am, 68, 93, 1980.
28.
SinghaU.K., JiangY., YuS., LuoM., LuY., ZhangJ., et al.Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3-E1 cells and primary mouse bone marrow stromal cells. J Cell Biochem, 103, 434, 2008.
29.
PollockR., GielM., LinherK., and ClacksonT.Regulation of endogenous gene expression with a small-molecule dimerizer. Nat Biotechnol, 20, 729, 2002.
30.
IndraccoloS., MoserleL., TisatoV., GolaE., MinuzzoS., RoniV., et al.Gene therapy of ovarian cancer with IFN-alpha-producing fibroblasts: comparison of constitutive and inducible vectors. Gene Ther, 13, 953, 2006.
31.
VilaboaN., FennaM., MunsonJ., RobertsS.M., and VoellmyR.Novel gene switches for targeted and timed expression of proteins of interest. Mol Ther, 12, 290, 2005.
32.
PengH., WrightV., UsasA., GearhartB., ShenH-C., CumminsJ., et al.Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest, 110, 751, 2002.
33.
PengH., UsasA., OlshanskiA., HoA.M., GearhartB., CooperG.M., et al.VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res, 20, 2017, 2005.
34.
PatelZ.S., YoungS., TabataY., JansenJ.A., WongM.E.K., and MikosA.G.Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone, 43, 931, 2008.
35.
YoungS., PatelZ.S., KretlowJ.D., MurphyM.B., MountziarisP.M., BaggettL.S., et al.Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A, 15, 2347, 2009.
36.
AslanH., ZilbermanY., ArbeliV., SheynD., MatanY., LiebergallM., et al.Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng, 12, 877, 2006.
37.
YaziciC., TakahataM., ReynoldsD.G., XieC., SamulskiR.J., SamulskiJ., et al.Self-complementary AAV2.5-BMP2-coated femoral allografts mediated superior bone healing versus live autografts in mice with equivalent biomechanics to unfractured femur. Mol Ther, 19, 1416, 2011.
38.
DupontK.M., BoerckelJ.D., StevensH.Y., DiabT., KolambkarY.M., TakahataM., et al.Synthetic scaffold coating with adeno-associated virus encoding BMP2 to promote endogenous bone repair. Cell Tissue Res, 347, 575, 2012.
39.
IshiharaA., BartlettJ.S., and BertoneA.L.Inflammation and immune response of intra-articular serotype 2 adeno-associated virus or adenovirus vectors in a large animal model. Arthritis, 2012, 735472, 2012.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
